Astellas Pharma’s Agensys subsidiary named Allergan’s Sef Kurstjens CEO and president, replacing founder Donald Rice, who is retiring. Kurstjens, MD, PhD, was SVP, chief medical officer and head of global drug development at Allergan. Agensys is developing a pipeline of fully human monoclonal antibodies to treat solid tumor cancers.

Bausch & Lomb named Mariano Garcia-Valiño president, Latin America. Valiño was most recently an operating partner at global private equity firm Advent International, focusing on investment opportunities in Latin American pharma, and worked at Pfizer from 2001 to 2009, having headed the company’s largest operating group in Brazil and led integration of Latin American operations during the Pfizer-Pharmacia merger.